Yiftah Barsheshet

1.0k total citations
15 papers, 652 citations indexed

About

Yiftah Barsheshet is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Yiftah Barsheshet has authored 15 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Biomedical Engineering. Recurrent topics in Yiftah Barsheshet's work include T-cell and B-cell Immunology (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Immune cells in cancer (3 papers). Yiftah Barsheshet is often cited by papers focused on T-cell and B-cell Immunology (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Immune cells in cancer (3 papers). Yiftah Barsheshet collaborates with scholars based in Israel, United States and Switzerland. Yiftah Barsheshet's co-authors include Nathan Karin, Gizi Wildbaum, Alon Vitenshtein, Sérgio A. Lira, Jeremy Griggs, Orly Avni, Yaniv Zohar, R. Alon, Christopher L. Karp and Rostislav Novak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yiftah Barsheshet

11 papers receiving 645 citations

Peers

Countries citing papers authored by Yiftah Barsheshet

Since Specialization

Citations

This map shows the geographic impact of Yiftah Barsheshet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiftah Barsheshet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiftah Barsheshet more than expected).

Fields of papers citing papers by Yiftah Barsheshet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiftah Barsheshet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiftah Barsheshet. The network helps show where Yiftah Barsheshet may publish in the future.

Co-authorship network of co-authors of Yiftah Barsheshet

This figure shows the co-authorship network connecting the top 25 collaborators of Yiftah Barsheshet. A scholar is included among the top collaborators of Yiftah Barsheshet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiftah Barsheshet. Yiftah Barsheshet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Abstract 4762: Tumor treating fields (TTFields) increase cancer cell membrane permeability and improve sensitivity to doxorubicin in vitro and in vivo 2024 ·Cancer Research ·(unknown), Tali Voloshin, (unknown), (unknown), Lilach Koren, Yaara Porat, (unknown), Noa Kaynan, (unknown), (unknown), (unknown), Yiftah Barsheshet, (unknown), Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti	3
2	Abstract 2030: N-cadherin-mediated activation of PI3K/Akt pathway following application of tumor treating fields (TTFields) 2024 ·Cancer Research ·(unknown), Tali Voloshin, (unknown), (unknown), Lilach Koren, (unknown), (unknown), (unknown), (unknown), Yiftah Barsheshet, (unknown), (unknown), (unknown), Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti	1
3	Abstract 6650: Macrophage pro-inflammatory phenotype skewing by the application of tumor treating fields (TTFields) 2024 ·Cancer Research ·(unknown), Yiftah Barsheshet, (unknown), (unknown), Tali Voloshin, (unknown), Lilach Koren, (unknown), (unknown), (unknown), (unknown), Adi Haber, Moshe Giladi, (unknown), Yoram Palti	0
4	Abstract 1738: Sensitizing cancer cell to doxorubicin by tumor treating fields (TTFields)-induced, elevated membrane permeability 2023 ·Cancer Research ·(unknown), Tali Voloshin, (unknown), (unknown), Lilach Koren, Yaara Porat, (unknown), Noa Kaynan, (unknown), (unknown), (unknown), Yiftah Barsheshet, (unknown), Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti	0
5	Abstract 1305: Tumor Treating Fields (TTFields) promote a pro-inflammatory phenotype in macrophages 2022 ·Cancer Research ·Yiftah Barsheshet, (unknown), Tali Voloshin, (unknown), Lilach Koren, (unknown), (unknown), (unknown), (unknown), (unknown), Moshe Giladi, Uri Weinberg, Yoram Palti	2
6	Ezh2 harnesses the intranuclear actin cytoskeleton to remodel chromatin in differentiating Th cells 2021 ·iScience ·(unknown), (unknown), (unknown), (unknown), (unknown), Yiftah Barsheshet, Orly Avni	9
7	726 Tumor Treating Fields (TTFields) induce an altered polarization program in M1/M2 macrophages 2021 ·SHILAP Revista de lepidopterología ·Yiftah Barsheshet, (unknown), Tali Voloshin, (unknown), Lilach Koren, (unknown), (unknown), (unknown), Moshe Giladi, (unknown), Yoram Palti	1
8	Schistosomal extracellular vesicle‐enclosed miRNAs modulate host T helper cell differentiation 2019 ·EMBO Reports ·Tal Meningher, Yiftah Barsheshet, Yifat Ofir‐Birin, Daniel Gold, (unknown), Elya Dekel, Yechezkel Sidi, Eli Schwartz, Neta Regev‐Rudzki, Orly Avni, Dror Avni	72
9	Combined loss of LAP1B and LAP1C results in an early onset multisystemic nuclear envelopathy 2019 ·Nature Communications ·Boris Fichtman, (unknown), (unknown), Yiftah Barsheshet, (unknown), Ziva Ben Neriah, Avraham Shaag, (unknown), Orly Elpeleg, Amnon Harel, Ronen Spiegel	38
10	Progesterone Increases Bifidobacterium Relative Abundance during Late Pregnancy 2019 ·Cell Reports ·Meital Nuriel‐Ohayon, Hadar Neuman, Ziv Oren, (unknown), Yiftah Barsheshet, Naamah Bloch, Atara Uzan, (unknown), Avi Peretz, Sigal Frishman, Moshe Hod, Eran Hadar, Yoram Louzoun, Orly Avni, Omry Koren	152
11	Social-Stress-Responsive Microbiota Induces Stimulation of Self-Reactive Effector T Helper Cells 2019 ·mSystems ·Michal Werbner, Yiftah Barsheshet, (unknown), (unknown), (unknown), Ziv Oren, (unknown), Evan Elliott, (unknown), (unknown), Omry Koren, Orly Avni	32
12	CCR8⁺FOXp3⁺T_regcells as master drivers of immune regulation 2017 ·Proceedings of the National Academy of Sciences ·Yiftah Barsheshet, Gizi Wildbaum, (unknown), Alon Vitenshtein, (unknown), Jeremy Griggs, Sérgio A. Lira, Nathan Karin	170
13	CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis 2017 ·Journal of Clinical Investigation ·Yaniv Zohar, Gizi Wildbaum, Rostislav Novak, Andrew L. Salzman, Marcus Thelen, R. Alon, Yiftah Barsheshet, Christopher L. Karp, Nathan Karin	6
14	CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis 2014 ·Journal of Clinical Investigation ·Yaniv Zohar, Gizi Wildbaum, Rostislav Novak, Andrew L. Salzman, Marcus Thelen, R. Alon, Yiftah Barsheshet, Christopher L. Karp, Nathan Karin	146
15	A Fusion Protein Encoding the Second Extracellular Domain of CCR5 Arrests Chemokine-Induced Cosignaling and Effectively Suppresses Ongoing Experimental Autoimmune Encephalomyelitis 2010 ·The Journal of Immunology ·(unknown), Alon Vitenshtein, Yiftah Barsheshet, Yaniv Zohar, Gizi Wildbaum, Nathan Karin	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact